Basics Absci Corporation Common Stock IPO Date: July 22, 2021 Sector: Healthcare Industry: Biotech Market Cap: $538.33M Activated in VL: True Average Daily Range Avg Daily Range: $0.22 | 4.40% Avg Daily Range (30 D): $0.12 | 3.56% Avg Daily Range (90 D): $0.13 | 3.86% Institutional Daily Volume Avg Daily Volume: 1.58M Avg Daily Volume (30 D): 4.15M Avg Daily Volume (90 D): 4.81M Trade Size Avg Trade Size (Sh.): 174 Avg Trade Size (Sh.) (30 D): 231 Avg Trade Size (Sh.) (90 D): 242 Institutional Trades Total Inst.Trades: 243 Avg Inst. Trade: $1.7M Avg Inst. Trade (30 D): $.72M Avg Inst. Trade (90 D): $.93M Avg Inst. Trade Volume: .38M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.82M Avg Closing Trade (30 D): $.73M Avg Closing Trade (90 D): $.99M Avg Closing Volume: 413.91K     News Oct 29, 2025 @ 8:05 PM Absci to Report Business Updates and Third Quarter... Source: Globe Newswire Oct 27, 2025 @ 12:00 PM Absci to Participate in Upcoming Investor Conferen... Source: Absci Corporation Oct 14, 2025 @ 3:41 PM Absci Stock Offers High-Risk AI Biotech Exposure W... Source: Nathan Reiff Oct 9, 2025 @ 3:00 PM Computer-Aided Drug Design (CADD) Market Competiti... Source: Towards Healthcare Sep 11, 2025 @ 4:10 PM Absci Boosts AI-Powered Drug Discovery With Oracle... Source: Vandana Singh Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.91 $-.2 $-.24 Diluted EPS $-.91 $-.2 $-.24 Revenue $ 2.82M $ .38M $ .59M Gross Profit $ $ $ Net Income / Loss $ -114.6M $ -28.71M $ -30.57M Operating Income / Loss $ -119.05M $ -30.15M $ -31.39M Cost of Revenue $ $ $ Net Cash Flow $ -28.28M $ -28.42M $ -8.84M PE Ratio